Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: CBER clinical holds

Executive Summary

CBER clinical holds: Center for Biologics Evaluation & Research will hold a meeting of the clinical hold review committee in February. FDA invites biological product companies to submit to the committee the name and number of any investigational biological product trial placed on clinical hold during the past 12 months that the company wants reviewed. Review requests should be submitted to FDA Chief Mediator and Ombudsman Amanda Pederson by Jan. 30, according to a Jan. 11 Federal Register notice...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS027479

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel